Genetic modification of hepatocytes towards hepatocyte transplantation and liver tissue engineering

Cell Transplantation

Volumn 15, Issue 1, 2006, Pages 1-12

  Kuge, Hiroyuki ^a   Ohashi, Kazuo ^a   Yokoyama, Takashi ^a   Kanehiro, Hiromichi ^a   Hisanaga, Michiyoshi ^a   Koyama, Fumikazu ^a   Bumgardner, Ginny L ^b   Kosai, Ken Ichiro ^c   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c KURUME UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Ex vivo gene therapy; Gene modification; Hepatocyte transplantation; Liver tissue engineering

Indexed keywords

UNIVERSITY OF WISCONSIN SOLUTION;

ADENOVIRUS VECTOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; CULTURE MEDIUM; DNA MODIFICATION; DOG; FEASIBILITY STUDY; GENE THERAPY; GENETIC TRANSDUCTION; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; KIDNEY CAPSULE; LIVER; LIVER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; SWINE; TISSUE ENGINEERING;

ADENOVIRIDAE; ANIMALIA; CANIS FAMILIARIS; SUIDAE; SUS SCROFA;

EID: 33645672386     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783982214     Document Type: Article

References (52)

1. Araki, K.; Imaizumi, T.; Okuyama, K.; Oike, Y.; Yamamura, K. Efficiency of recombination by Cre transient expression in embryonic stem cells: Comparison of various promoters. J. Biochem. (Tokyo) 122:977-982; 1997.
2. Beizer, F. O.; Southard, J. H. Principles of solid-organ preservation by cold storage. Transplantation 45:673-676; 1988.
3. Bergelson, J. M.; Cunningham, J. A.; Droguett, G.; Kurt-Jones, E. A.; Krithivas, A.; Hong, J. S.; Horwitz, M. S.; Crowell, R. L.; Finberg, R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323; 1997.
4. Bernai, R. M.; Sharma, S.; Gardner, B. K.; Douglas, J. T.; Bergelson, J. M.; Dubinett, S. M.; Batra, R. K. Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. Clin. Cancer Res. 8:1915-1923; 2002.
5. Berry, M. N.; Friend, D. S. High-yield preparation of isolated rat liver parenchymal cells: A biochemical and fine structural study. J. Cell. Biol. 43:506-520; 1969.
6. Bissell, D. M.; Arenson, D. M.; Maher, J. J.; Roll, F. J. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J. Clin. Invest. 79:801-812; 1987.
7. Bumgardner, G. L.; Li, J.; Heininger, M.; Ferguson, R. M.; Orosz, C. G. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 65:47-52; 1998.
8. Cai, J.; Ito, M.; Nagata, H.; Westerman, K. A.; Lafleur, D.; Chowdhury, J. R.; Leboulch, P.; Fox, I. J. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology 36:386-394; 2002.
9. Chirmule, N.; Propert, K.; Magosin, S.; Qian, Y.; Qian, R.; Wilson, J. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6:1574-1583; 1999.
10. Csete, M. E.; Drazan, K. E.; van Bree, M.; McIntee, D. F.; McBride, W. H.; Bett, A.; Graham, F. L.; Busuttil, R. W.; Berk, A. J.; Shaked, A. Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in cold-preserved hepatocytes. Transplantation 57:1502-1507; 1994.
11. Chowdhury, J. R.; Grossman, M.; Gupta, S.; Chowdhury, N. R.; Baker, Jr., J. R.; Wilson, J. M. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 254:1802-1805; 1991.
12. Demetriou, A. A.; Brown, Jr., R. S.; Busuttil, R. W.; Fair, J.; McGuire, B. M.; Rosenthal, P.; Am Esch, 2nd, J. S.; Lerut, J.; Nyberg, S. L.; Salizzoni, M.; Fagan, E. A.; de Hemptinne, B.; Broelsch, C. E.; Muraca, M.; Salmeron, J. M.; Rabkin, J. M.; Metselaar, H. J.; Pratt, D.; De La Mata, M.; McChesney, L. P.; Everson, G. T.; Lavin, P. T.; Stevens, A. C.; Pitkin, Z.; Solomon, B. A. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239:660-667; 2004.
13. Eguchi, S.; Kamlot, A.; Ljubimova, J.; Hewitt, W. R.; Lebow, L. T.; Demetriou, A. A.; Rozga, J. Fulminant hepatic failure in rats: Survival and effect on blood chemistry and liver regeneration. Hepatology 24:1452-1459; 1996.
14. Fabrega, A. J.; Fasbender, A. J.; Struble, S.; Zabner, J. Cationic lipid-mediated transfer of the hIL-10 gene prolongs survival of allogeneic hepatocytes in Nagase an albuminemic rats. Transplantation 62:1866-1871; 1996.
15. Fox, I. J.; Chowdhury, J. R.; Kaufman, S. S.; Goertzen, T. C.; Chowdhury, N. R.; Warkentin, P. I.; Dorko, K.; Sauter, B. V.; Strom, S. C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338:1422-1426; 1998.
16. Fox, I. J.; Chowdhury, J. R. Hepatocyte transplantation. J. Hepatol. 40:878-886; 2004.
17. Greber, U. F.; Willetts, M.; Webster, P.; Helenius, A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486; 1993.
18. Grossman, M.; Raper, S. E.; Kozarsky, K.; Stein, E. A.; Engelhardt, F.; Muller, D.; Lupien, P. J.; Wilson, J. M. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat. Genet. 6:335-341; 1994.
19. Gupta, S.; Rajvanshi, P.; Sokhi, R.; Slehria, S.; Yam, A.; Kerr, A.; Novikoff, P. M. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29:509-519; 1999.
20. Hsu, S. M.; Raine, L. Protein A, avidin, and biotin in immunohistochemistry. J. Histochem. Cytochem. 29:1349-1353; 1981.
21. Kanegae, Y.; Lee, G.; Sato, Y.; Tanaka, M.; Nakai, M.; Sakaki, T.; Sugano, S.; Saito, I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:3816-3821; 1995.
22. Kay, M. A.; Baley, P.; Rothenberg, S.; Leland, F.; Fleming, L.; Ponder, K. P.; Liu, T.; Finegold, M.; Darlington, G.; Pokorny, W. Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc. Natl. Acad. Sci. USA 89:89-93; 1992.
23. Kay, M. A.; Landen, C. N.; Rothenberg, S. R.; Taylor, L. A.; Leland, F.; Wiehle, S.; Fang, B.; Bellinger, D.; Finegold, M.; Thompson, A. R.; Read, M.; Brinkhous, K. M.; Woo, S. L. C. In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91:2353-2357; 1994.
24. Kay, M. A.; Glorioso, J. C.; Naldini, L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7:33-40; 2001.
25. Koyama, F.; Sawada, H.; Hirao, T.; Fujii, H.; Hamada, H.; Nakano, H. Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil. Eur. J. Cancer 36:2403-2410; 2000.
26. Kulig, K. M.; Vacanti, J. P. Hepatic tissue engineering. Transpl. Immunol. 12:303-310; 2004.
27. Leopold, P. L.; Ferris, B.; Grinberg, I.; Worgall, S.; Hackett, N. R.; Crystal, R. G. Fluorescent virions: Dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 10:367-378; 1998.
28. Malhi, H.; Annamaneni, P.; Slehria, S.; Joseph, B.; Bhargava, K. K.; Palestro, C. J.; Novikoff, P. M.; Gupta, S. Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology 36:112-121; 2002.
29. Muraca, M.; Gerunda, G.; Neri, D.; Vilei, M. T.; Granato, A.; Feltracco, P.; Meroni, M.; Giron, G.; Burlina, A. B. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 359:317-318; 2002.
30. Nakamura, T.; Sato, K.; Hamada, H. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J. Virol. 77:2512-2521; 2003.
31. Newsome, P. N.; Tsiaoussis, J.; Masson, S.; Buttery, R.; Livingston, C.; Ansell, I.; Ross, J. A.; Sethi, T.; Hayes, P. C.; Plevris, J. N. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 40:636-645; 2004.
32. Nguyen, T. H.; Oberholzer, J.; Birraux, J.; Majno, P.; Morel, P.; Trono, D. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol. Ther. 6:199-209; 2002.
33. Ohashi, K.; Tsutsumi, M.; Tsujiuchi, T.; Kobitsu, K.; Okajima, E.; Nakajima, Y.; Nakano, H.; Takahashi, M.; Mori, Y.; Konishi, Y. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicine-induced cell cycle disturbance in partially hepatectomized rats. Cancer Res. 56:3474-3479; 1996.
34. Ohashi, K.; Marion, P. L.; Nakai, H.; Meuse, F; Cullen, J. M.; Bordier, B. B.; Schwall, R.; Greenberg, H. B.; Glenn, J. S.; Kay, M. A. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6:327-331; 2000.
35. Ohashi, K.; Park, F.; Kay, M. A. Hepatocyte transplantation: Clinical and experimental application. J. Mol. Med. 79:617-630; 2001.
36. Ohashi, K.; Meuse, L.; Schwall, R.; Kay, M. A. cMet activation allows persistent engraftment of ectopically transplanted xenogenic human hepatocytes in mice. Transplant. Proc. 33:587-588; 2001.
37. Ohashi, K.; Park, F.; Kay, M. A. Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. Hum. Gene Ther. 20:653-663; 2002.
38. Ohashi, K.; Park, F.; Schwall, R.; Kay, M. A. Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector. Transplant. Proc. 34:1431-1433; 2002.
39. Ohashi, K.; Kay, M. A. Extracellular matrix component cotransplantation prolongs survival of heterotopically transplanted human hepatocytes in mice. Transplant. Proc. 36:2469-2470; 2004.
40. Ohashi, K.; Waugh, J. M.; Dake, M. D.; Yokoyama, T.; Kuge, H.; Nakajima, Y.; Yamanouchi, M.; Naka, H.; Yoshioka, A.; Kay, M. A. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases. Hepatology 41:132-140; 2005.
41. Ohashi, K.; Kay, M. A.; Yokoyama, T.; Kuge, H.; Nakajima, Y. Stability and repeat regeneration potential of the engineered liver tissue under the kidney capsule in mice. Cell Transplant. 14:621-627; 2005.
42. Olivares, E. C.; Hollis, R. P.; Chalberg, T. W.; Meuse, L.; Kay, M. A.; Calos, M. P. Site-specific genomic integration produces therapeutic factor IX levels in mice. Nat. Biotechnol. 20:1124-1128; 2002.
43. Olthoff, K. M.; Judge, T. A.; Gelman, A. E.; daShen, X.; Hancock, W. W.; Turka, L. A.; Shaked, A. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat. Med. 4:194-200; 1998.
44. Raper, S. E.; Grossman, M.; Rader, D. J.; Thoene, J. G.; Clark, 3rd, B. J.; Kolansky, D. M.; Muller, D. W.; Wilson, J. M. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann. Surg. 223:116-126; 1996.
45. Runge, D.; Runge, D. M.; Drenning, S. D.; Bowen, Jr., W. C.; Grandis, J. R.; Michalopoulos, G. K. Growth and differentiation of rat hepatocytes: Changes in transcription factors HNF-3, HNF-4, STAT-3, and STAT-5. Biochem. Biophys. Res. Commun. 250:762-768; 1998.
46. Schneider, A.; Attaran, M.; Gratz, K. F.; Bleck, J. S.; Winkler, M.; Manns, M. P.; Ott, M. Intraportal infusion of 99mtechnetium-macro-aggregrated albumin particles and hepatocytes in rabbits: Assessment of shunting and portal hemodynamic changes. Transplantation 75:296-302; 2003.
47. Smaglik, P. Tighter watch urged on adenoviral vectors . . . with proposal to report all 'adverse events'. Nature 402:707; 1999.
48. Strom, S.; Fisher, R. Hepatocyte transplantation: New possibilities for therapy. Gastroenterology 124:568-571; 2003.
49. Takahashi, Y.; Geller, D. A.; Gambotto, A.; Watkins, S. C.; Fung, J. J.; Murase, N. Adenovirus-mediated gene therapy to liver grafts: Successful gene transfer by donor pretreatment. Surgery 128:345-352; 2000.
50. Takesue, M.; Maruyama, M.; Shibata, N.; Kunieda, T.; Okitsu, T.; Sakaguchi, M.; Totsugawa, T.; Kosaka, Y.; Arata, A.; Ikeda, H.; Matsuoka, J.; Oyama, T.; Kodama, M.; Ohmoto, K.; Yamamoto, S.; Kurabayashi, Y.; Yamamoto, I.; Tanaka, N.; Kobayashi, N. Maintenance of cold-preserved porcine hepatocyte function with UW solution and ascorbic acid-2 glucoside. Cell Transplant. 12:599-606; 2003.
51. Wickham, T. J.; Mathias, P.; Cheresh, D. A.; Nemerow, G. R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319; 1993.
52. Yant, S. R.; Ehrhardt, A.; Mikkelsen, J. G.; Meuse, L.; Pham, T.; Kay, M. A. Transposition from a gutless adenotrasposon vector stabilizes transgene expression in vivo. Nat. Biotechnol. 20:999-1005; 2002.